| COVID-19 |
1 |
1 |
| Abdominal Pain |
0 |
0.48 |
| Abdominal Bloating |
0 |
0.47 |
| Nerve |
0 |
0.41 |
| Abdominal Infection |
0 |
0.38 |
| Pancreatitis |
0 |
0.38 |
| Pain Management |
0 |
0.29 |
| Peptic Ulcer Disease |
0 |
0.29 |
| Renal Disease |
0 |
0.29 |
| Abdomen |
0 |
0.28 |
| Acute Pancreatitis |
0 |
0.28 |
| Brain |
0 |
0.28 |
| Kidney |
0 |
0.28 |
| Pain |
0 |
0.28 |
| Biliary Disease |
0 |
0.27 |
| Constipation |
0 |
0.26 |
| Diarrhea |
0 |
0.26 |
| Cardiovascular Risk Management |
0 |
0.23 |
| Gastroesophageal Reflux Disease |
0 |
0.23 |
| Chronic Kidney Disease |
0 |
0.22 |
| Renal Failure |
0 |
0.22 |
| Hypertension |
0 |
0.21 |
| Cardiometabolic Risk Factors |
0 |
0.2 |
| Irritable Bowel Syndrome |
0 |
0.17 |
| Gastritis |
0 |
0.15 |
| Acute Gastritis |
0 |
0.14 |
| Cardiovascular disease |
0 |
0.14 |
| Cholangitis |
0 |
0.14 |
| Dyspepsia |
0 |
0.14 |
| Epidemiology |
0 |
0.14 |
| Geriatrics |
0 |
0.14 |
| Heart |
0 |
0.14 |
| Hyperlipidemia |
0 |
0.14 |
| Intensive Care Unit |
0 |
0.14 |
| Massachusetts |
0 |
0.14 |
| Pandemic |
0 |
0.14 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.14 |
| Primary Care |
0 |
0.14 |
| Stomach |
0 |
0.14 |
| Washington |
0 |
0.14 |
| Helicobacter Pylori |
0 |
0.12 |
| Lipids Management |
0 |
0.09 |
| Obesity |
0 |
0.09 |